IMM

Immupharma Plc

Top Reasons for Hospital Admissions in Lupus

A 20-year long retrospective analysis of 814 systemic lupus erythematosus (SLE)-related hospitalizations of 339 SLE patients, reveals some interesting new patterns in lupus disease from hospitalization rates to disease complications

Immupharma Plc

Depression & Lupus: Is There a Connection?

The prevalence and severity of depression among people with autoimmune diseases like rheumatoid arthritis, psoriasis, Crohn’s disease, and systemic lupus erythematosus (SLE) appears to be high, according to data from recent

Immupharma Plc

Pregnancy outcomes greatly improved in lupus patients

Historically, pregnancy in patients with systemic lupus erythematosus (SLE) was considered so risky that physicians counseled women to avoid becoming pregnant and recommended that women carrying a child terminate their

Immupharma Plc

Immupharma PLC Subscription to raise £2.66 million

Commenting, ImmuPharma’s Chairman, Tim McCarthy, said: “We are delighted to be welcoming back Lanstead as a significant shareholder of the Company. Lanstead has been very supportive of the Company since

STRIX GROUP PLC ORD 1P
Strix Group plc CEO Mark Bartlett discusses the company's focus on safety controls, global reach, innovation, and growth opportunities for investors.
Firering Strategic MineralS PLC
Learn about Firering Strategic Minerals plc's operations and future plans from an exclusive interview with their Independent Non-Executive Director, Vassilios Carellas.
Pulsar Helium Inc
Discover insights into the helium sector as Stephane Foucard delves into the projects of junior companies, assessing key criteria for commercial viability.
Golden Matrix Group Inc
Golden Matrix Group Inc. CEO Brian Goodman discusses revenue growth, acquisitions, and global markets in an exclusive interview with DirectorsTalk.
XP Factory plc
XP Factory plc's CEO discusses financial highlights, growth targets, and a £10 million credit facility with Barclays in an exclusive interview with DirectorsTalk.